Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Knoll claims another series of heteroarylsulfonamide compounds for CNS and other disorders

Oct. 15, 1998

Modulators of neurotransmitter function claimed by Hoechst Marion Roussel for depression, PD

Oct. 15, 1998

Pharmacia & Upjohn launches new antidepressant in Germany

Oct. 15, 1998

Treatment recommendations for generalized convulsive status epilepticus emerge from VA study

Oct. 14, 1998

Roche presents series of OFQ (ORL1) receptor agonists/antagonists

Oct. 14, 1998

Stroke patients benefit from treatment with anti-ICAM-1 MAb

Oct. 14, 1998

New heteroarylsulfonamide derivatives from Knoll with broad clinical application

Oct. 14, 1998

Pharmos successfully completes phase II head trauma study

Oct. 13, 1998

5-HT2C agonist shows potential for treating OCD and depression

Oct. 13, 1998

Lundbeck develops new antipsychotic agents acting on D1 receptors

Oct. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...